European healthcare systems face paying more for drugs or losing access to new treatments as a result of Donald Trump’s push for the global medicines industry to cut prices in the US, industry experts have warned.
Global drugmakers are in talks…
European healthcare systems face paying more for drugs or losing access to new treatments as a result of Donald Trump’s push for the global medicines industry to cut prices in the US, industry experts have warned.
Global drugmakers are in talks…